沛嘉醫療:成功應用HighLife系統完成第二例二尖瓣置換手術,手術耗時持續下降
格隆匯1月28日丨2022年1月28日,四川大學華西醫院心臟內科陳茂教授團隊成功應用Peijia HighLife TSMVR系統,完成該系統的第二例經股靜脈房間隔二尖瓣置換手術(TSMVR), 這也是TSMVR技術在亞洲的第二例應用。手術過程順利,整個手術耗時約2小時20分鐘,較前一次的手術時間縮短了約20多分鐘。其中繞環步驟(looping)一次成功,用時約30多分鐘,也較前次手術縮短。術後即刻經超聲心動圖進行評估:二尖瓣返流消失,無瓣周漏,人工瓣膜植入位置理想,形態良好,無左室流出道梗阻。本次手術進一步驗證了產品的有效性和易操作性,術者能較快縮短學習曲線,並隨着手術流程的不斷優化和標準化,顯著降低手術時間。沛嘉公司將持續推進Peijia HighLife TSMVR手術在中國的臨牀應用,造福更多患者!
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.